You Wear Extra Large
After lunch, Shen Qi brought a young woman to visit and learn at the Shen Qi Research Center.
Her name is Lucy Walker, and she is a technology business leader at GLK Pharmaceutical Company in the UK.
Shen Qi's approach to negotiating with the British delegation was to first discuss macro-level issues, and then, when it came to specific technical details, to hold small group discussions based on their respective areas of expertise.
Bald-headed Laurie and old man West were led away by Shen Qi's men.
Ms. Lucy Walker was personally accompanied by Shen Qi.
The British called her Miss Walker, which meant that Miss Walker was not yet married.
British girls are cute and playful as children, sexy and beautiful when they are young, but they also age quickly.
As they age, rotten teeth, freckles, and obesity become nightmares for British women.
Comparing photos of the same British girl at age 18 and 28, many people would exclaim in surprise, "Is this the same person?"
Some say Beckham's wife has had several children, yet she seems to grow younger and more beautiful with each passing year. How does she do it?
The reason is simple: Beckham's wife is rich.
Miss Walker was young, beautiful, voluptuous, and elegant.
"Miss Walker, this way please." Shen Qi led Miss Walker to his Director's Office, closed the door, and locked it.
Miss Walker smiled charmingly, "Call me Lucy."
Shen Qi was very direct; he didn't like beating around the bush when it came to women. "Tell me, Lucy, how much?"
"Oh, it's so hot." Lucy took off her blazer, fanning herself with her hands, then held up a hand. "Five hundred million."
Shen Qi shook his head, clearly dissatisfied. "So little? Only five hundred million?"
Lucy added, "Five hundred million Pound Sterling."
Shen Qi: "Even five hundred million Pound Sterling isn't much. Is it too much or too little?"
"Hmm?" Lucy hummed calmly, curiously looking around Shen Qi's office, seemingly very interested in everything there.
Suddenly, Lucy was drawn to a set of books in Shen Qi's bookcase. She was very surprised. "Harry Potter! Professor Shen is actually reading Harry Potter!"
Shen Qi explained, "I bought it for my daughter."
"How old is your daughter?" Lucy asked.
"Four years old."
"Can a four-year-old Chinese girl understand J.K. Rowling's original English version of Harry Potter?" Lucy is not brainless.
"My daughter is a genius." Shen Qi's face beamed with pride and happiness when he talked about his daughter.
How could a four-year-old girl read foreign novels when she probably hasn't even fully recognized all the characters in her native language?
Lucy, anyway, didn't believe it.
"Is it okay if I read English novels and my daughter listens?"
"That explanation is reasonable, but your daughter is only four years old, and it's already quite impressive that she can understand English novels."
"Lucy, let's talk about Kang Shun."
Kang Shun, a diabetes medication, is a flagship product of Ou Beiqi Pharmaceutical. Miss Lucy has already investigated the relationship between Shen Qi and Ou Beiqi Pharmaceutical.
Compared to international pharmaceutical giant GLK, the Chinese private pharmaceutical company Ou Beiqi Pharmaceutical is not even in the same league.
International pharmaceutical giants typically have generic drug acquisition departments. After the patent protection of their original drugs expires, a large number of generic drugs will emerge on the market. The generic drug acquisition departments of international pharmaceutical giants simply buy all these generic drugs, and sometimes even buy the small pharmaceutical factories that produce generic drugs.
Kang Shun is not a generic drug; it has its own independent patent rights.
When faced with original drugs from other companies, international pharmaceutical giants still resort to the same strategy: buy, buy, buy!
To acquire Lipitor, the American giant Pfizer directly purchased Warner-Lambert for $90 billion. Lipitor was an original drug developed by Warner-Lambert.
Lipitor has rewarded Pfizer with annual sales exceeding $10 billion, making it a classic business case.
Lipitor is a drug for treating cardiovascular diseases. In Shen Qi's eyes, their family's diabetes drug, Kang Shun, is a miracle drug on par with Lipitor.
Miss Lucy held up her hand and said five hundred million Pound Sterling, a price Shen Qi clearly couldn't accept.
Why does Shen Qi want to sell Kang Shun?
They're short of money.
With private assets worth billions of RMB, why would he need more money?
Nonsense, who doesn't need money these days?
"Kang Shun is a good medicine, but GLK can only offer a maximum of Pound Sterling 500 million." Lucy smiled, her interest returning to the books on Shen Qi's shelf. "Macbeth, are you going to read this play to your daughter too?"
"Macbeth is the British version of a palace intrigue novel," Shen Qi shook his head and said, "No, I personally really like this story; I read it often."
"In terms of drama, Hamlet is far superior." Lucy discovered that she and Professor Shen shared many common interests.
"Lucy, regarding Kang Shun, it seems we have a significant price difference, so I don't think it's necessary to continue negotiating. In any case, you're still very welcome to come to China." Even if a deal falls through, Shen Qi maintained a courteous demeanor.
"I will be staying in China for the next few years, Professor Shen. We will have many more opportunities to cooperate." Lucy was young, but she casually offered to discuss a 500 million Pound Sterling deal. Although the deal didn't go through, 500 million Pound Sterling is no small sum.
Lucy investigated Shen Qi, Shen Qi similarly investigated Miss Lucy Miss Walker's background.
GLK's major shareholder is James Walker, who has a son and a daughter with his wife and an illegitimate child with his mistress.
Lucy Walker is the daughter of James Walker and his wife, and her future career path will likely involve a powerful female shareholder or something similar.
"Professor Shen, as soon as I arrived at your center, you took me to your private office. May I visit your drug development laboratory?" Lucy made a request.
"Of course." Shen Qi then led Lucy downstairs to their laboratory.
"I heard you're developing a new chemical drug to treat rare anemia?" Lucy asked as they walked.
Given GLK's intelligence-gathering capabilities, it wouldn't be difficult for them to obtain some information about Shen Qi Research Center.
The specific technical details are definitely unattainable; if we did obtain them, it would constitute transnational espionage.
Shen Qi didn't hide anything. "Yes, it's under development."
"Producing and selling rare drugs, Ou Beiqi Pharmaceutical shouldn't have any experience, right?" Lucy wasn't there to sell anything; she had done her homework. Through her company's intelligence network, she learned that the LPJK1 project hadn't even entered the animal testing phase when its patent development rights were sold to Ou Beiqi Pharmaceutical.
Shen Qi admitted, "Compared to GLK, no company dares to say they have more experience in the production and sales of rare drugs. We've arrived; this is our laboratory."